NUTEK OIDO LTD

Pioneering precision in surgical oncology, NUTEK develops the Rainbow Probe. An AI-powered, handheld hyperspectral imaging device that enables real-time detection of residual cancerous tissue on the patient's body during surgery. Its technology transforms tumor removal from surgeon’s subjective estimation to objective, data-driven precision, reducing re-operations and improving patient outcomes. NUTEK’s first application is breast cancer. Backed by a multidisciplinary leadership team and proven clinical validation, NUTEK is positioned to disrupt the multi-billion-dollar guided surgery market.